Actuate Therapeutics Inc (ACTU)
NASDAQ: ACTU
· Real-Time Price · USD
7.80
-0.03 (-0.38%)
At close: Oct 16, 2025, 3:59 PM
7.80
0.00%
After-hours: Oct 16, 2025, 04:10 PM EDT
-0.38% (1D)
| Bid | 7.8 |
| Market Cap | 161.8M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.68M |
| EPS (ttm) | -3.11 |
| PE Ratio (ttm) | -2.51 |
| Forward PE | -6.32 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 8.2 |
| Volume | 196,078 |
| Avg. Volume (20D) | 84,128 |
| Open | 7.90 |
| Previous Close | 7.83 |
| Day's Range | 7.54 - 8.20 |
| 52-Week Range | 5.47 - 11.99 |
| Beta | -0.21 |
| Ex-Dividend Date | n/a |
About ACTU
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACTU
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACTU stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-19.15%
Actuate Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
1 month ago
+7.18%
Actuate Therapeutics shares are trading lower after the company announced an underwritten public offering.